by American Thoracic Society Credit: Pixabay/CC0 Public Domain Avacopan was better than prednisone in reducing respiratory as well as ear, nose and throat (ENT) involvement in ANCA-associated vasculitis patients participating in the phase 3 ADVOCATE trial, and enabled reduced glucocorticoid use. Study results were published at the ATS 2022 international conference. The study was a...
